Global Hemostasis and Tissue Sealing Agents Market Research Report 2024

Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.

Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.

The global Hemostasis and Tissue Sealing Agents market was valued at US$ 3559.5 million in 2023 and is anticipated to reach US$ 4961.4 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent is about 64%.

Hemostasis and Tissue Sealing Agents is widely used for Minimally Invasive Surgery, General Surgery and other field. The most proportion of Hemostasis and Tissue Sealing Agents is used for general surgery, and the proprotion is 44%.

North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.

Market competition is not intense. Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution and Pfizer, etc. are the leaders of the industry, with about 70% market shares.

This report aims to provide a comprehensive presentation of the global market for Hemostasis and Tissue Sealing Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostasis and Tissue Sealing Agents.

Report Scope

The Hemostasis and Tissue Sealing Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostasis and Tissue Sealing Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hemostasis and Tissue Sealing Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation


By Company


Johnson & Johnson

Baxter

C R Bard

B Braun

Gelita

Integra Life Sciences

Advance Medical Solution

Pfizer

CSL Behring

CryoLife

Zimmer Biomet

Ferrosan Medical Devices

Medtronic

Smith & Nephew

Z-Medica

Cohera Medical

Marine Polymer

Equimedical


Segment by Type


Hemostasis Agents

Tissue Sealing Agents


Segment by Application


Minimally Invasive Surgery

General Surgery

Others


Consumption by Region


North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Hemostasis and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Hemostasis and Tissue Sealing Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Frequently Asked Questions